(S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine.N-acetyl-L-glutamic acid salt Cas：219921-94-5
Pharmaceutical Materials 2025-03-02
(S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine.N-acetyl-L-glutamic acid salt (CAS No. 219921-94-5) is a significant pharmaceutical intermediate primarily utilized in the synthesis of drug molecules with specific pharmacological activities, particularly as an intermediate for repaglinide. This compound appears as a white or off-white solid powder with a purity of ≥99%. Its molecular formula is C23H37N3O5, and its molecular weight is 435.557.
The structural features of this compound include a substituted benzene ring and an N-acetyl-L-glutamic acid salt group, which impart unique chemical properties and reactivity. In drug development, this intermediate may undergo multi-step organic synthesis reactions, such as substitution and condensation, to introduce various pharmacophoric groups, thereby generating drug candidates with therapeutic potential.
Although direct pharmacological data on this compound are currently limited, its role as a pharmaceutical intermediate suggests that the final product may possess therapeutic value, especially in the treatment of diabetes. Research on this compound in the fields of chemical synthesis and drug discovery continues, highlighting its potential applications in the pharmaceutical industry.
| Property | Details |
|---|---|
| CAS Number | 219921-94-5 |
| Molecular Formula | C23H37N3O5 |
| Molecular Weight | 435.557 g/mol |
| Appearance | White or off-white solid powder |
| Purity | ≥99% |
| Application | Pharmaceutical intermediate, used in the synthesis of drug molecules with specific pharmacological activities, particularly as an intermediate for repaglinide |
| Structure Features | Substituted benzene ring, N-acetyl-L-glutamic acid salt group |
| Synthesis | Multi-step organic synthesis reactions, such as substitution, condensation, etc. |
| Pharmacological Activity | Data currently limited, but the final product may have therapeutic value, especially in the treatment of diabetes |
| Research Status | Studied in chemical synthesis and drug discovery, with potential applications in the pharmaceutical industry |
,Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
